IL2 and neoplasm: When the dissociated tumors of hu-BLT mice were used as targets for primary IL-2 activated NK cells in Cr-release assay, tumors from sNK cells alone or sNK cells combined with CDDP treated mice were killed much less when compared to untreated tumor-bearing mice (Figure 4E).